Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Rituximab-Cont'

Rituximab-Cont published presentations and documents on DocSlides.

Patients with total IgG <400 mg/dL while receiving rituximab should
Patients with total IgG <400 mg/dL while receiving rituximab should
by ivy
NOT. receive IgG replacement therapy. . AAIFNC F...
Carfilzomib , Rituximab and Dexamethasone (
Carfilzomib , Rituximab and Dexamethasone (
by mindeeli
CaRD. ) Is Highly . Active and . Offers a Neuropat...
227 EMEA 2005 Since all the treatment regimens used so far have only
227 EMEA 2005 Since all the treatment regimens used so far have only
by priscilla
Zevalin, supplied as kit for radiopharmaceutical p...
rials as treatment options for eligible patients
rials as treatment options for eligible patients
by elysha
Page 1 of 13 Note : Consider C linical T . Wa...
Published in nejm in sep 2016
Published in nejm in sep 2016
by Wildboyz
RITUXIMAB IN B-LINEAGE ADULT ACUTE LYMPHOBLASTIC L...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Indolent Non-Hodgkin L
Indolent Non-Hodgkin L
by danika-pritchard
ymphoma. Sobia Ozair. March 8, 2017. MD Anderson ...
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)
by ellena-manuel
Swiss Group for Clinical Cancer Research (SAKK). ...
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and
by celsa-spraggs
Emerging Treatments . Description of Program. Thi...
Please note, these are the actual video-recorded proceeding
Please note, these are the actual video-recorded proceeding
by luanne-stotts
Moderator. Neil Love, MD. Mollie Moran, MSN, CNP,...
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by tatiana-dople
Contemporary Treatment Strategies and Optimal Seq...
Update on Follicular Lymphoma:
Update on Follicular Lymphoma:
by alexa-scheidler
Contemporary Treatment Strategies and Optimal Seq...
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Recent developments in the treatment of DLBCL
Recent developments in the treatment of DLBCL
by payton
Prof. Georg Lenz, MD. Department of Haematology, O...
Translating the biology of diffuse large B-cell lymphoma into treatment
Translating the biology of diffuse large B-cell lymphoma into treatment
by callie
Prof. . Alexey V. Danilov, MD, PhD,. 1. Dr. Massi...
Sartorius Stedim Biotech have developed a suite of binding assays using the
Sartorius Stedim Biotech have developed a suite of binding assays using the
by harper
iQue. ®. Screener PLUS (. IntelliCyt. ). The . i...
Understanding Lymphoma Series
Understanding Lymphoma Series
by jones
Helpline: 800 500 9976 | helpline@lymphoma.org U...
ContentslistsavailableatBloodReviewsjournalhomepagewwwelseviercoml
ContentslistsavailableatBloodReviewsjournalhomepagewwwelseviercoml
by oconnor
Diagnosisandtreatmentofautoimmunehemolyticanemiain...
AuthorsAcceptedManuscriptCryoglobulinemicvasculitisandskinulcersOurth
AuthorsAcceptedManuscriptCryoglobulinemicvasculitisandskinulcersOurth
by danya
www.elsevier.com/locate/semarthrit Our therapeutic...
CASE REPORT
CASE REPORT
by willow
33 37 EN Recurrent Mixed Cryoglobulinemia (MCS): ...
Understanding Lymphoma Series
Understanding Lymphoma Series
by evans
Helpline: 800 500 9976 | helpline@lymphoma.org U...
BC Cancer Protocol Summary LYCHOPRMTXPage of
BC Cancer Protocol Summary LYCHOPRMTXPage of
by melody
Activated: 1 Jun 2014 Revised: Mar 2022tests rev...
266 Cancer Control
266 Cancer Control
by iris
Gum Drop Mushrooms . Photograph courtesy of Sherri...
Practice Guidelines
Practice Guidelines
by roy
Clinical Haematology, University Hospital Liège a...
Module 3: Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
Paolo Ghia, 1 Andrzej Pluta,
Paolo Ghia, 1 Andrzej Pluta,
by HappyHippo
2. Malgorzata Wach,. 3. Daniel Lysak,. 4. Tomas...
In the name of god brief review on
In the name of god brief review on
by SugarAndSpice
nhl. Presenting by . F.Malek. M.D. Assistant Prof...
Thyroid eye disease B.Eshraghi
Thyroid eye disease B.Eshraghi
by brown
M.D. Associate professor of ophthalmology. Ophthal...
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
by isabella2
Dr. Gilles SALLES. Chief . of. . the. . Lymphoma...
PAPS Bled with Anti-coagulation, Infected with Immunosuppression and Ineffective IVIG,
PAPS Bled with Anti-coagulation, Infected with Immunosuppression and Ineffective IVIG,
by stella
What’s Next?. Abo Baker . Ahmd. . Mosa. , MD. U...
Antibody-based Therapies
Antibody-based Therapies
by osullivan
Dr. John Kuruvilla. Princess Margaret Cancer Centr...
MEDICATION GUIDE
MEDICATION GUIDE
by audrey
ZYDELIGzyeDELigidelalisibtabletsWhat is the most i...
Part B Medical Drugs Requiring StepTherapy
Part B Medical Drugs Requiring StepTherapy
by natalie
Drug subject to Step Therapy BRAND NAME GENERIC NA...
Part B Medical Drugs Requiring Step
Part B Medical Drugs Requiring Step
by udeline
-TherapyDrug subject to Step TherapyTry these Opti...
Cheson B et al. Proc ASH
Cheson B et al. Proc ASH
by pattyhope
2016;Abstract 615; Sehn LH. et al. . Lancet . Onc...
Mature Results from ECOG Study E1405 — A Phase II Study of
Mature Results from ECOG Study E1405 — A Phase II Study of
by webraph
VcR. -CVAD with Maintenance Rituximab for Previous...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
Drug Treatment of Hematopoietic Malignancy
Drug Treatment of Hematopoietic Malignancy
by mitsue-stanley
Munir Gharaibeh, MD, PhD, MHPE. Department of Pha...